Tatiana Lebedeva

Title: Tatiana Lebedeva: Innovator in Monoclonal Antibodies

Introduction

Tatiana Lebedeva is a prominent inventor based in Aston, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work focuses on the production and application of antibodies that specifically bind to naloxone and naltrexone.

Latest Patents

Tatiana holds a patent for "Anti-naloxone and anti-naltrexone monoclonal antibodies and methods of production and use thereof." This patent discloses antibodies that specifically bind naloxone or naltrexone. It also includes conjugates used in the production of these antibodies, as well as methods for their production. Furthermore, the patent outlines methods for using these antibodies in direct assays for naloxone or naltrexone. Additionally, it describes techniques for reducing naloxone or naltrexone interference in opiate assays using the antibodies.

Career Highlights

Tatiana is currently employed at Siemens Healthcare Diagnostics GmbH, where she continues to advance her research and development efforts. Her work has the potential to significantly impact the medical field, particularly in the area of drug testing and treatment.

Collaborations

Tatiana collaborates with notable colleagues, including Manoj Sharma and Tatiana Mareeva. Their combined expertise enhances the innovative projects they undertake together.

Conclusion

Tatiana Lebedeva is a trailblazer in the field of monoclonal antibodies, with a focus on naloxone and naltrexone. Her contributions are paving the way for advancements in medical diagnostics and treatment methodologies.